AJP - GI Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Gastrointest Liver Physiol 262: G996-G1001, 1992;
0193-1857/92 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sieber, C. C.
Right arrow Articles by Groszmann, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sieber, C. C.
Right arrow Articles by Groszmann, R. J.

AJP - Gastrointestinal and Liver Physiology, Vol 262, Issue 6 996-1001, Copyright © 1992 by American Physiological Society

ARTICLES

In vitro hyporeactivity to methoxamine in portal hypertensive rats: reversal by nitric oxide blockade

C. C. Sieber and R. J. Groszmann
Hepatic Hemodynamic Laboratory, Veterans Affairs Medical Center, West Haven, Connecticut.

The endothelial cell plays an important role in the local control of vascular smooth muscle tone. Portal hypertension is accompanied by systemic vasodilatation and a decreased response to vasoconstrictors, changes especially evident in the superior mesenteric arterial bed. To evaluate a possible effect of the locally released endothelium-derived relaxing factor nitric oxide (NO), we tested the effect of NO blockade in in vitro perfused superior mesenteric arterial beds of normal (sham) and portal hypertensive (PVL) rats, induced by partial portal vein ligation. A significant (n = 7/group; P = 0.02) hyporeactivity to the vasoconstrictive properties of the alpha-adrenoceptor agonist methoxamine (3 x 10(-6) to 3 x 10(-4) M) was prevented by blocking NO formation in PVL compared with sham rats, using the stereospecific biosynthesis antagonist N omega-nitro-L-arginine (10(-4) M, n = 7/group; NS for all methoxamine concentrations tested). This effect was reversed by the NO precursor L-arginine (10(-3) M, n = 5/group). In conclusion, these in vitro results in mesenteric vessels demonstrate that 1) portal hypertension is accompanied by a hyporeactivity to the vasopressor methoxamine and 2) locally released NO in this preparation is responsible for the decreased vasoconstrictive response.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
Y. Iwakiri, G. Cadelina, W. C. Sessa, and R. J. Groszmann
Mice with targeted deletion of eNOS develop hyperdynamic circulation associated with portal hypertension
Am J Physiol Gastrointest Liver Physiol, November 1, 2002; 283(5): G1074 - G1081.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
V. Shah, R. Wiest, G. Garcia-Cardena, G. Cadelina, R. J. Groszmann, and W. C. Sessa
Hsp90 regulation of endothelial nitric oxide synthase contributes to vascular control in portal hypertension
Am J Physiol Gastrointest Liver Physiol, August 1, 1999; 277(2): G463 - G468.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
R. Wiest, V. Shah, W. C. Sessa, and R. J. Groszmann
NO overproduction by eNOS precedes hyperdynamic splanchnic circulation in portal hypertensive rats
Am J Physiol Gastrointest Liver Physiol, April 1, 1999; 276(4): G1043 - G1051.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online